DURECT

Class [005]
Pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, metabolic dysfunction-associated steatohepatitis, gout, arthritis and anemia, diseases and disorders of the endocrine system, namely, thyroid disorders, inflammatory diseases and disorders, namely, inflammatory bowel diseases and inflammatory connective tissue diseases, autoimmune diseases and disorders, namely, multiple sclerosis and graves disease, cancer, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, central nervous system diseases and disorders, namely, cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies, acute organ injury, namely, alcohol-associated hepatitis, epigenetic diseases and disorders, namely, Angelman's syndrome, Prader-Willi syndrome, and DNA methyltransferase (DNMT)-associated diseases and disorders, namely, schizophrenia.